Rijken DC - Search Results

1

Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver.

Otter M, Kuiper J, van Berkel TJ, Rijken DC. Otter M, et al. Among authors: rijken dc. Ann N Y Acad Sci. 1992 Dec 4;667:431-42. doi: 10.1111/j.1749-6632.1992.tb51645.x. Ann N Y Acad Sci. 1992. PMID: 1339243 Review. No abstract available.

2

Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.

van der Kaaden ME, Rijken DC, Groeneveld E, van Berkel TJ, Kuiper J. van der Kaaden ME, et al. Among authors: rijken dc. Thromb Haemost. 1995 Aug;74(2):722-9. Thromb Haemost. 1995. PMID: 8585013

3

Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.

Kuiper J, Otter M, Voorschuur AH, van Zonneveld AJ, Rijken DC, van Berkel TJ. Kuiper J, et al. Among authors: rijken dc. Thromb Haemost. 1995 Nov;74(5):1298-304. Thromb Haemost. 1995. PMID: 8607113

4

Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.

Kuiper J, Van't Hof A, Otter M, Biessen EA, Rijken DC, van Berkel TJ. Kuiper J, et al. Among authors: rijken dc. Biochem J. 1996 Feb 1;313 ( Pt 3)(Pt 3):775-80. doi: 10.1042/bj3130775. Biochem J. 1996. PMID: 8611154 Free PMC article.

5

Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.

Biessen EA, van Teijlingen M, Vietsch H, Barrett-Bergshoeff MM, Bijsterbosch MK, Rijken DC, van Berkel TJ, Kuiper J. Biessen EA, et al. Among authors: rijken dc. Circulation. 1997 Jan 7;95(1):46-52. doi: 10.1161/01.cir.95.1.46. Circulation. 1997. PMID: 8994415

6

The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.

van der Kaaden ME, Rijken DC, Kruijt JK, van Berkel TJ, Kuiper J. van der Kaaden ME, et al. Among authors: rijken dc. Thromb Haemost. 1997 Apr;77(4):710-7. Thromb Haemost. 1997. PMID: 9134648

7

Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.

Noorman F, Barrett-Bergshoeff MM, Biessen EA, van de Bilt E, van Berkel TJ, Rijken DC. Noorman F, et al. Among authors: rijken dc. Hepatology. 1997 Nov;26(5):1303-10. doi: 10.1053/jhep.1997.v26.pm0009362376. Hepatology. 1997. PMID: 9362376

8

Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.

Otter M, Van Berkel TJ, Rijken DC. Otter M, et al. Among authors: rijken dc. Thromb Haemost. 1989 Sep 29;62(2):667-72. Thromb Haemost. 1989. PMID: 2510347

9

Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells.

Kuiper J, Otter M, Rijken DC, van Berkel TJ. Kuiper J, et al. Among authors: rijken dc. J Biol Chem. 1988 Dec 5;263(34):18220-4. J Biol Chem. 1988. PMID: 3142872 Free article.

10

Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.

Otter M, Kuiper J, Bos R, Rijken DC, van Berkel TJ. Otter M, et al. Among authors: rijken dc. Biochem J. 1992 Jun 1;284 ( Pt 2)(Pt 2):545-50. doi: 10.1042/bj2840545. Biochem J. 1992. PMID: 1318035 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters